The partners will use 4D Path's imaging-based Q-Plasia OncoReader in a Phase II trial testing doublet and triplet regimens comprising Trodelvy, Padcev, and Keytruda.

Uvalde trial: Former school police officer found not guilty on all counts Minneapolis software engineers greeted with insults after mistakenly ID'd as ICE agents ...

ACON Laboratories, Inc. today announced the retail availability of the first FDA-cleared home test which allows families to identify four major respiratory infections, including Respiratory Syncytial ...

Deep-learning analysis of routine H&E slides accurately predicts key NSCLC driver mutations, supporting treatment in lung cancer care.

During a scheduled qualification trial on Tuesday evening, Neutron's Stage 1 tank experienced a structural rupture. A rupture ...

People may wish to change their personalities, but according to new research showing the benefits of self-acceptance, this ...

Personality assessments can help us understand who we truly are, both our strengths and weaknesses, as well as our hidden aspects. They provide a way for us to identify ourselves as unique and measure ...

Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...

Major spirits brands are sitting on a massive $22 billion glut of unsold inventory: Report Inside Blake Lively's messages to Ben Affleck, Matt Damon about 'It Ends With Us' ...

Microsoft alone runs approximately 100,000 A/B tests each year to continuously optimize products. A famous Gmail experiment, ...

Nationally, about one in three survivors of sexual assault ever report their experiences to law enforcement, according to the Rape, Abuse, & Incest National Network. Texas is betting that gap is ...